Delivery Order SPE2DB24D1021-SPE2DB25FEWTN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive federal medical supply relationship with DLA, leveraging the company's established...
- The Defense Logistics Agency awarded a $1,525.72 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $1,743.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of October 29, 2025. This competitively awarded contract, issued without set-aside provisions, leverages AmerisourceBergen's position as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,823.10 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 8, 2025, with completion scheduled for July 9, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $35,386.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors, with performance at the company's Conshohocken, Pennsylvania facility and completion by June 2, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- The Defense Logistics Agency awarded a $5,025.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.03 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order represents a pediatric and adult diabetes management product sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEWTNDelivery Order
The Defense Logistics Agency awarded a $2,167.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on May 14, 2025, with completion targeted for May 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical and medical supply relationship with DLA. The sensors will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal healthcare procurement needs. This award falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999 million through December 2026, which serves as the company's primary vehicle for supplying pharmaceuticals and medical devices to military and veteran healthcare systems worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has demonstrated consistent capability to fulfill diverse medical supply requirements through competitive federal procurement processes. The Dexcom G7 continuous glucose monitoring sensors support diabetes management capabilities within the Defense Health Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 5/14/25 |